Baidu
map

Nature:科学家揭示糖蛋白怎样保护呼吸道

2014-01-24 中国科学报 田天

肺黏膜表面是防御由空气传播的病原体的第一道防线,但黏液过度生成本身也能造成呼吸病。这项研究发现,被称为Muc5b的呼吸道黏液的一个特定糖蛋白成分是小鼠的黏液纤毛清除所必需的。 令人吃惊的是,对有过敏性哮喘的小鼠和人类来说,Muc5b还通过对巨噬细胞功能的调控贡献于针对细菌感染的先天性防御。Muc5b的缺失造成物质在呼吸道中积累,最终导致由多种细菌引起的慢性感染。 这项研究对于呼吸道疾病的治疗可

肺黏膜表面是防御由空气传播的病原体的第一道防线,但黏液过度生成本身也能造成呼吸病。这项研究发现,被称为Muc5b的呼吸道黏液的一个特定糖蛋白成分是小鼠的黏液纤毛清除所必需的。

令人吃惊的是,对有过敏性哮喘的小鼠和人类来说,Muc5b还通过对巨噬细胞功能的调控贡献于针对细菌感染的先天性防御。Muc5b的缺失造成物质在呼吸道中积累,最终导致由多种细菌引起的慢性感染。

这项研究对于呼吸道疾病的治疗可能会有意义。

原文出处

Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza M, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O'Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM.Muc5b is required for airway defence.Nature. 2014 Jan 16

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879886, encodeId=18fb18e988626, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 16 19:44:00 CST 2014, time=2014-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282360, encodeId=195e128236000, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sun Jan 26 01:44:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627231, encodeId=257f162e23178, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Sun Jan 26 01:44:00 CST 2014, time=2014-01-26, status=1, ipAttribution=)]
    2014-07-16 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879886, encodeId=18fb18e988626, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 16 19:44:00 CST 2014, time=2014-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282360, encodeId=195e128236000, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sun Jan 26 01:44:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627231, encodeId=257f162e23178, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Sun Jan 26 01:44:00 CST 2014, time=2014-01-26, status=1, ipAttribution=)]
    2014-01-26 zhmscau
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879886, encodeId=18fb18e988626, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 16 19:44:00 CST 2014, time=2014-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282360, encodeId=195e128236000, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Sun Jan 26 01:44:00 CST 2014, time=2014-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627231, encodeId=257f162e23178, content=<a href='/topic/show?id=8ea0e6863a2' target=_blank style='color:#2F92EE;'>#糖蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76863, encryptionId=8ea0e6863a2, topicName=糖蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d6621112920, createdName=chentianping, createdTime=Sun Jan 26 01:44:00 CST 2014, time=2014-01-26, status=1, ipAttribution=)]

相关资讯

Nat Immunol:艾滋病患者抗体反应为何较弱?

为什么HIV病人抗体反应比较弱?现在一项刊登在《自然—免疫学》上论文给出的答案:位于HIV 病毒表面的糖蛋白gp120可让人体B免疫细胞失去活性。 人们已经发现 HIV 能够引起 CD4+ 辅助性T免疫细胞不断丧失,导致免疫系统功能受损、其他感染更容易乘机而入。但人们一直没有弄清为何在 HIV 感染早期,T细胞数量还处于相对正常时,人体就不产生有力的抗体反应了。 在这项研究中,来自美国

Science:研究揭示艾滋病毒感染机制

  利用超分辨率显微镜,研究人员证实在攻击宿主细胞前HIV-1病毒包膜蛋白(envelope protein)会聚集在一起。这对于成功地感染到底有多么重要呢?   你被欺骗了:一个HIV颗粒的外表并不像科学家们和艺术家们长期以来描绘的那样像一个长刺的Koosh球。尽管病毒包膜有超过100个糖蛋白刺突的空间,在它的表面实际上只保留了大约10个蛋白。科学家们推测这可能是对免疫系统的一种防御——越少的

Baidu
map
Baidu
map
Baidu
map